Federal Court Rules on Ownership of Androxal Patents
Repros Therapeutics Inc. announced Dec. 29 that a federal judge in Texas has issued a definitive ruling finding correct inventorship for two of the company’s Androxal patents, confirming that Repros Therapeutics is the sole and rightful owner of the patents, U.S. Patent No. 7,759,360 (the “‘360 patent”) and U.S. Patent No. 7,737,185 (the “‘185 patent”).
Calling Dr. Harry Fisch’s claims of co-inventorship “strained to the point of absurdity,” Judge Vanessa Gilmore of the U.S. District Court for the Southern District of Texas found that Dr. Fisch “contributed nothing to the actual invention” of the ‘360 patent. She also found “an absence of material facts to support a finding of co-inventorship” of the ‘185 patent.
A release from Repros stated:
Dr. Fisch, a New York urologist and fertility specialist, has made numerous statements, including to the news media, that he was a co-inventor and had contributed to the conception of the patents.
Repros filed suit against Dr. Fisch in August 2013 seeking a declaratory judgment of ownership and inventorship of the ‘360 and ‘185 patents regarding the treatment of hypogonadism in men. In the lawsuit, the Company asserted that Repros’ President and CEO, Joseph S. Podolski, was correctly named as the sole inventor of the ‘360 patent, and that he and Repros Vice President of Research and Development, Ronald Wiehle, were correctly named as co-inventors of the ‘185 patent.
In October 2013, Dr. Fisch filed counterclaims against Repros as well as against Mr. Podolski and Dr. Wiehle, seeking correction of inventorship of these patents.
On the basis of equitable estoppel and an absence of material facts to support a finding of co-inventorship in the case of each of the patents, the court granted both of Repros’ motions for summary judgment and denied Dr. Fisch’s motion for summary judgment.
The decision confirms Repros’ rights to the Androxal patents.
A Texas jury has awarded hedge-fund firm Highland Capital Management $40 million in its lawsuit against Credit Suisse over inflated appraisals of a dozen luxury properties, the Wall Street Journal reports.
A North Carolina employment case before a federal appeals court illustrates the significant amount of time and money an employer had to invest to stave off post-trial issues driven by the former employee’s request for attorneys’ fees, reports HR.BLR.com.
A lawsuit alleges Gilead Sciences
Winstead presents a complimentary on-demand webinar discussing the pros and cons of pre-judgment and post-judgment remedies.
The Washington Legal Foundation has posted a free on-demand webinar discussing the Spokeo case currently before the U.S. Supreme Court and the issue of “no-injury” class actions.
Google and Verizon have entered into a long-term patent cross-license agreement intended to thwart lawsuits from trolls, PC Magazine reports.
If legislators won’t pass tougher gun control, the argument goes, then crusading lawyers will seek justice in court. But the strategy hasn’t worked in the past—and it won’t work in the future. But Bloomberg Businessweek says gun-control advocates’ plans have some basic weaknesses.
The Harvard Law School Program on Dispute Resolution offers a free white paper offering advice on understanding how relationships can help someone to negotiate even the most difficult conversations.
Ten groups of top technology, media and business organizations on Dec. 15 filed legal briefs in support of Microsoft’s argument to a federal appeals court that the U.S. government cannot issue a search warrant to obtain customers’ e-mails held in another country, reports The Washington Post.
Some former employees of Sony Pictures Entertainment have filed a suit forcing the company to defend the security measures it took in advance of the hack.
The Washington Legal Foundation presents a complimentary webinar on the clash between statutes and the Constitution in non-injury class actions.
The U.S. Supreme Court will hear a case that asks whether a company discriminates by refusing to provide a simple accommodation to an expectant mother.
When patent attorney Michael Sander and his colleagues started noticing that some judges on the Patent Trial and Appeal Board (PTAB) were rejecting more patents than others, Sander built a predictive tool that tells an attorney with a new PTAB case his chances of success, based on an instant, computer analysis of every similar case handled by the same judge, Wired reports.
EDRM, the leading standards organization for the e-discovery market, has released an updated Statistical Sampling Applied to Electronic Discovery. The release, published on the EDRM website, is open for public comment. At the conclusion of the public comment period on January 9, 2015, input will be reviewed and considered for incorporation before the updated materials are finalized.
Cisco Systems filed a suit on Dec. 5 against Arista Networks, a networking switch company and fast-moving competitor, accusing it of copying large amounts of Cisco’s work, reports The New York Times.